- 5 Ergebnisse
Kleinster Preis: € 69,90, größter Preis: € 275,18, Mittelwert: € 160,49
1
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer / Michail Ignatiadis (u. a.) / Buch / Recent Results in Cancer Research / Englisch / 2012 / Springer-Verlag GmbH - Ignatiadis, Michail
Bestellen
bei booklooker.de
€ 69,90
Bestellengesponserter Link
Ignatiadis, Michail:

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer / Michail Ignatiadis (u. a.) / Buch / Recent Results in Cancer Research / Englisch / 2012 / Springer-Verlag GmbH - gebunden oder broschiert

2012, ISBN: 9783642281594

[ED: Gebunden], [PU: Springer-Verlag GmbH], Most deaths from carcinomas are caused by the hematogenous dissemination of cancer cells to distant organs and the eventual development of meta… Mehr…

Versandkosten:Zzgl. Versandkosten., zzgl. Versandkosten Buchbär
2
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer / Michail Ignatiadis (u. a.) / Buch / Recent Results in Cancer Research / HC runder Rücken kaschiert / XIV / Englisch / 2012 - Ignatiadis, Michail
Bestellen
bei booklooker.de
€ 144,74
Versand: € 0,001
Bestellengesponserter Link

Ignatiadis, Michail:

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer / Michail Ignatiadis (u. a.) / Buch / Recent Results in Cancer Research / HC runder Rücken kaschiert / XIV / Englisch / 2012 - gebunden oder broschiert

2012, ISBN: 9783642281594

[ED: Gebunden], [PU: Springer-Verlag GmbH], This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breas… Mehr…

Versandkosten:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) Buchbär
3
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Ignatiadis, Michail (Herausgeber); Pantel, Klaus (Herausgeber); Sotiriou, Christos (Herausgeber)
Bestellen
bei Achtung-Buecher.de
€ 162,49
Versand: € 0,001
Bestellengesponserter Link
Ignatiadis, Michail (Herausgeber); Pantel, Klaus (Herausgeber); Sotiriou, Christos (Herausgeber):
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - gebunden oder broschiert

2012

ISBN: 3642281591

2012 Gebundene Ausgabe Brust / Mammakarzinom, Brustkrebs, Krebs (Krankheit) / Brustkrebs, Krebs (Krankheit) / Mammakarzinom, Frauenarzt, Frauenheilkunde, Gynäkologie - Gynäkologe, Krebs… Mehr…

Versandkosten:Sans frais d'envoi en Allemagne. (EUR 0.00) MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien
4
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Ignatiadis, Michail (EDT); Sotiriou, Christos (EDT); Pantel, Klaus (EDT)
Bestellen
bei AbeBooks.fr
€ 275,18
Versand: € 14,591
Bestellengesponserter Link
Ignatiadis, Michail (EDT); Sotiriou, Christos (EDT); Pantel, Klaus (EDT):
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - gebunden oder broschiert

2012, ISBN: 3642281591

[EAN: 9783642281594], D'occasion, comme neuf, [SC: 14.59], [PU: Springer], Unread book in perfect condition., Books

NOT NEW BOOK. Versandkosten: EUR 14.59 GreatBookPrices, Columbia, MD, U.S.A. [5352716] [Note: 5 (sur 5)]
5
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Ignatiadis, Michail (EDT); Sotiriou, Christos (EDT); Pantel, Klaus (EDT)
Bestellen
bei AbeBooks.fr
€ 150,16
Versand: € 14,591
Bestellengesponserter Link
Ignatiadis, Michail (EDT); Sotiriou, Christos (EDT); Pantel, Klaus (EDT):
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - gebunden oder broschiert

2012, ISBN: 3642281591

[EAN: 9783642281594], Nouveau livre, [SC: 14.59], [PU: Springer], Books

NEW BOOK. Versandkosten: EUR 14.59 GreatBookPrices, Columbia, MD, U.S.A. [5352716] [Note: 5 (sur 5)]

1Da einige Plattformen keine Versandkonditionen übermitteln und diese vom Lieferland, dem Einkaufspreis, dem Gewicht und der Größe des Artikels, einer möglichen Mitgliedschaft der Plattform, einer direkten Lieferung durch die Plattform oder über einen Drittanbieter (Marketplace), etc. abhängig sein können, ist es möglich, dass die von eurobuch angegebenen Versandkosten nicht mit denen der anbietenden Plattform übereinstimmen.

Bibliographische Daten des bestpassenden Buches

Details zum Buch
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.

Detailangaben zum Buch - Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer


EAN (ISBN-13): 9783642281594
ISBN (ISBN-10): 3642281591
Gebundene Ausgabe
Erscheinungsjahr: 2012
Herausgeber: Springer Berlin
253 Seiten
Gewicht: 0,540 kg
Sprache: Englisch

Buch in der Datenbank seit 2007-07-25T05:23:28+02:00 (Berlin)
Detailseite zuletzt geändert am 2024-02-11T15:46:20+01:00 (Berlin)
ISBN/EAN: 9783642281594

ISBN - alternative Schreibweisen:
3-642-28159-1, 978-3-642-28159-4
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: pant, pantel, michail, klaus christ, ign, christos, sotiriou peter nikolaus mina
Titel des Buches: cancer, tumors the breast, this serious one breast, mini, cel, residu, tum, min minim, minimal art, tumor, sang homericus


Daten vom Verlag:

Autor/in: Michail Ignatiadis; Christos Sotiriou; Klaus Pantel
Titel: Recent Results in Cancer Research; Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer
Verlag: Springer; Springer Berlin
254 Seiten
Erscheinungsjahr: 2012-04-23
Berlin; Heidelberg; DE
Gedruckt / Hergestellt in Niederlande.
Sprache: Englisch
160,49 € (DE)
164,99 € (AT)
177,00 CHF (CH)
POD
XIV, 254 p.

BB; Hardcover, Softcover / Medizin/Klinische Fächer; Onkologie; Verstehen; Medizin, Gesundheit; Breast cancer; Circulating nucleic acids; Circulating tumor cells; Micrometastasis; Minimal residual disease; surgical oncology; Oncology; Gynecology; Cancer Therapy; Pathology; Cancer Biology; Gynäkologie und Geburtshilfe; Pathologie; BC

Minimal residual disease and circulating tumor cells in breast cancer: Open questions for research.- Minimal residual disease and breast cancer metastasis.- Self-seeding in cancer.- Microenvironments dictating tumor cell dormancy.- Technologies for circulating tumor cell (CTC) and disseminated tumor cell (DTC) detection and characterization.- Immunomagnetic separation technologies.- Microfluidic technologies for the isolation of CTCs.- EPISPOT assay: Detection of viable disseminating tumor cells in solid tumor patients.- Advances in optical technologies for rare cell detection and characterization.- Size-based enrichment technologies for circulating tumor cell (CTC) detection and characterization.- Emerging technologies for CTC detection based on depletion of normal cells.- Molecular assays for the detection and characterization of CTCs.- Multiplex molecular analysis of CTCs.- Other blood-based biomarkers.- Circulating DNA and next generation sequencing.- Circulating microRNAs as non-invasive biomarkers in breast cancer.- Circulating endothelial cells and circulating endothelial progenitors.- Disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) in breast cancer clinical research and practice.- Bone marrow DTCs.- CTCs in primary breast cancer.- CTCs in early breast cancer.- CTCs in metastatic breast cancer.- HER2-positive DTCs/CTCs in breast cancer.- DTCs and CTCs in breast cancer – 5 decades later.- Drug and circulating tumor cell co-development.- Challenges in drug and biomarker co-development.- Challenges and opportunities in the use of CTCs for companion diagnostic development.

Most deaths from carcinomas are caused by the hematogenous dissemination of cancer cells to distant organs and the eventual development of metastases. When found in the bone marrow or peripheral blood of carcinoma patients, occult cancer cells are referred to as disseminated tumor cells (DTCs) or circulating tumor cells (CTCs). CTCs and DTCs are considered surrogates of minimal residual disease, i.e., the presence of malignant cells in distant organs that are undetectable by conventional imaging and laboratory tests used for tumor staging after curative surgery of the primary tumor.

 

In this book, leading investigators in the field provide up-to-date information on a series of important questions, including:

 

-  How can the study of minimal residual disease and CTCs help us to better understand breast cancer metastasis?

-  What technologies are available for the detection and characterization of CTCs and DTCs, and what are their relative merits?

-  How are DTCs and CTCs relevant to clinical research and practice?

- What is the role of other blood-based biomarkers such as circulating endothelial cells and circulating nucleic acids?

-  What are the challenges in drug and biomarker co-development and the use of CTCs for companion diagnostic development?

 

Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients

Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs)

Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers


Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs) Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers Includes supplementary material: sn.pub/extras

< zum Archiv...